References
- Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Pediatrics 1995; 96: 758–64.
- Bartlett JG. IDCP guidelines: management of upper respiratory tract infections. Infect Dis Clin Pract 1997; 6: 212–20.
- Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Diagnosis and management of Group A streptococcal pharyngitis: a practical guideline. Clin Infect Dis 1997; 25: 574–83.
- Norrby SR, Rabie WJ, Bacart P, Mueller O, Leroy B, Rangaraju M, Butticaz-Iroudayassamy E. Efficacy of short-course therapy with the ketolide telithromycin compared with 10 days of penicillin V in the treatment of pharyngitis/tonsillitis. Scand J Infect Dis 2002; 33: 883–90.
- Nagai K, Appelbaum PC, Davies TA, Kelly LM, Hoellman DB, Andrasevic AT, et al. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and eastern European countries. Antimicrob Agents Chemother 2002; 46: 546–9.
- Farrell DJ, Morrissey I, Bakker S, Felmingham D. Molecular characterization of macrolide mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT study 1999–2000. J Antimicrob Chemother 2002; 50 (Suppl S1): 39–47.
- Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med 2002; 346: 1200–6.
- Gehanno P, Passot V, Nabet P, Sultan E. Telithromycin (HMR 3647) penetrates rapidly into tonsillar tissue achieving high and prolonged tonsillar concentrations (Abstract). Clin Microbiol Infect 2000; 6 (Suppl 1): 204.
- Pichichero ME, Casey JR, Mayes T, Francis AB, Marsocci SM, Murphy AM, Hoeger W. Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies. Pediatr Infect Dis J 2000; 19: 917–23.